Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
33%
Ph not_applicable
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

withdrawn133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnnot_applicable

Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia

NCT01373372
completedearly_phase_1

Effects of Hormone Stimulation on Brain Scans for Cushing s Disease

NCT01459237
completed

Gender and Neural Substrates of Stress and Craving

NCT00756925

Clinical Trials (3)

Showing 3 of 3 trials
NCT01373372Not Applicable

Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia

Withdrawn
NCT01459237Early Phase 1

Effects of Hormone Stimulation on Brain Scans for Cushing s Disease

Completed
NCT00756925

Gender and Neural Substrates of Stress and Craving

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3